Table 3.

Demographics of the 141 sample high dimensional proteomics dataset from Blume et al. who analyzed depleted plasma and used nanoparticle coronas to distinguish cancer-free individuals from early non-small cell lung cancer patients

	Cancer-free (n = 80)	Non-small cell lung cancer (n = 61)
Number of males, n (%)	31 (39)	31 (51)
Mean (standard deviation) age, years	65 (8)	67 (8)
Number of each stage of cancer, n (%)
Stage 1	N/A	23 (38)
Stage 2		7 (11)
Stage 3		31 (51)

Individuals in the Blume et al. dataset were age- and sex-matched. Ethnicity, pack-year smoking history and molecular subtypes of non-small cell lung cancer were not shown by Blume et al.⁷